Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Milestone Pharmaceuticals Inc. (MIST)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-K/AS-1/A
   
Operating expenses       
Research and development, net of tax credits  38.734.542.016.8 
General and administrative  12.410.37.03.11.5
Commercial  7.05.98.93.9 
    Loss from operations  -43.1-50.7-57.9-23.8-8.3
Interest income  0.20.72.60.7 
    Net loss and comprehensive loss  -42.9-50.0-55.2-23.2 
Weighted average number of shares and pre-funded warrants outstanding, basic  41.829.3   
Weighted average number of shares and pre-funded warrants outstanding, diluted  41.829.3   
   
Net loss per share, basic  ($1.02)($1.70)($3.50)$72.63$236,750.00
Net loss per share, diluted  ($1.02)($1.70)($3.50)$72.63$236,750.00

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy